Medika d.d.
ISIN: HRMDKARA0000 | Ticker: MDKA | LEI: 74780000O0R8ZVGJJO27
Country: Croatia
Medika supplies pharmacies, healthcare facilities, hospitals, community health centres, outpatient clinics, medical practices, pharmaceutical wholesalers and specialized shops with the widest range of products of all pharmaceutical wholesalers. Drawing on the tradition and an innovative approach to day-to-day business operations, Medika sets new standards in the quality of service which has helped it retain the market leader position for over five decades.
Way back since 1922, Medika has been developing and making progress at the highest level of quality, value and innovation in the pharmaceutical industry. We know that knowledge acquired through continuous education is more effective if complemented by experience gained through years of work. Proud of our tradition, we are ready to continuously innovate and improve quality. Due to experience and new knowledge, Medika nowadays faces a successful future.
1922
Served areaWorldwide
HeadquartersCapraška 1, 10000 Zagreb – Croatia
| Line item in (hrk) | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 |
|---|---|---|---|---|
| Assets | N/A | 2,592,463,000.00 | N/A | 2,329,076,000.00 |
| Noncurrent Assets | N/A | 491,142,000.00 | N/A | 546,803,000.00 |
| Property Plant And Equipment | N/A | 181,714,000.00 | N/A | 232,588,000.00 |
| Investments In Subsidiaries | N/A | 24,195,000.00 | N/A | 25,856,000.00 |
| Noncurrent Receivables | N/A | 11,822,000.00 | N/A | 5,371,000.00 |
| Deferred Tax Assets | N/A | 746,000.00 | N/A | 999,000.00 |
| Current Assets | N/A | 2,101,321,000.00 | N/A | 1,782,273,000.00 |
| Inventories | N/A | 373,563,000.00 | N/A | 356,486,000.00 |
| Trade And Other Current Receivables | N/A | 1,649,226,000.00 | N/A | 1,340,680,000.00 |
| Cash and cash equivalents | 53,421,000.00 | 78,468,000.00 | 78,468,000.00 | 85,107,000.00 |
| Equity And Liabilities | N/A | 2,592,463,000.00 | N/A | 2,329,076,000.00 |
| Equity | 504,628,000.00 | 545,527,000.00 | 545,527,000.00 | 638,928,000.00 |
| Issued Capital | N/A | 164,399,000.00 | N/A | 191,429,000.00 |
| Retained Earnings | N/A | 313,768,000.00 | N/A | 380,139,000.00 |
| Other Reserves | N/A | 67,360,000.00 | N/A | 67,360,000.00 |
| Noncurrent Liabilities | N/A | 61,537,000.00 | N/A | 121,164,000.00 |
| Noncurrent Provisions | N/A | 1,334,000.00 | N/A | 1,414,000.00 |
| Noncurrent Payables | N/A | N/A | N/A | 28,438,000.00 |
| Deferred Tax Liabilities | N/A | 17,696,000.00 | N/A | 19,350,000.00 |
| Noncurrent Portion Of Noncurrent Loans Received | N/A | N/A | N/A | 34,378,000.00 |
| Current Liabilities | N/A | 1,985,399,000.00 | N/A | 1,568,984,000.00 |
| Current Provisions | N/A | 1,198,000.00 | N/A | 342,000.00 |
| Trade And Other Current Payables To Trade Suppliers | N/A | 1,666,705,000.00 | N/A | 1,526,346,000.00 |
| Current Tax Liabilities Current | N/A | 10,475,000.00 | N/A | 11,459,000.00 |
| Line item in (hrk) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
|---|---|---|
| Revenue | 3,989,597,000.00 | 4,130,394,000.00 |
| Advertising Expense | -5,063,000.00 | -8,274,000.00 |
| Employee Benefits Expense | -133,025,000.00 | -142,633,000.00 |
| Depreciation And Amortisation Expense | -26,795,000.00 | -29,218,000.00 |
| Other Expense By Nature | -47,306,000.00 | -51,859,000.00 |
| Other Gains Losses | -8,660,000.00 | 1,487,000.00 |
| Profit Loss From Operating Activities | 97,251,000.00 | 111,883,000.00 |
| Finance Income | 1,728,000.00 | 10,593,000.00 |
| Finance Costs | -7,515,000.00 | -4,457,000.00 |
| Profit Loss Before Tax | 93,762,000.00 | 120,856,000.00 |
| Income Tax Expense Continuing Operations | -16,888,000.00 | -21,347,000.00 |
| Profit (loss) | 76,874,000.00 | 99,509,000.00 |
| Line item in (hrk) | 01.01.2021 | 02.01.2020 | 01.01.2022 | 02.01.2021 |
|---|---|---|---|---|
| Profit (loss) | 76,874,000.00 | N/A | 99,509,000.00 | N/A |
| Adjustments For Income Tax Expense | 16,888,000.00 | N/A | 21,347,000.00 | N/A |
| Adjustments For Decrease Increase In Inventories | 4,888,000.00 | N/A | 9,789,000.00 | N/A |
| Adjustments For Depreciation And Amortisation Expense | 26,795,000.00 | N/A | 29,218,000.00 | N/A |
| Adjustments For Provisions | -6,000.00 | N/A | -776,000.00 | N/A |
| Adjustments For Unrealised Foreign Exchange Losses Gains | -2,303,000.00 | N/A | 1,590,000.00 | N/A |
| Adjustments For Sharebased Payments | N/A | N/A | 5,018,000.00 | N/A |
| Other Adjustments For Noncash Items | -9,000.00 | N/A | 13,000.00 | N/A |
| Adjustments For Losses Gains On Disposal Of Noncurrent Assets | 7,000.00 | N/A | N/A | N/A |
| Cash Flows From Used In Operations | 124,853,000.00 | N/A | 358,788,000.00 | N/A |
| Interest Paid Classified As Operating Activities | -7,310,000.00 | N/A | -4,750,000.00 | N/A |
| Income Taxes Paid Refund Classified As Operating Activities | -9,149,000.00 | N/A | -20,643,000.00 | N/A |
| Cash Flows From Used In Operating Activities | 108,394,000.00 | N/A | 333,395,000.00 | N/A |
| Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | 901,000.00 | N/A | 2,711,000.00 | N/A |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | -10,059,000.00 | N/A | -63,747,000.00 | N/A |
| Proceeds From Sales Of Intangible Assets Classified As Investing Activities | -2,528,000.00 | N/A | -10,550,000.00 | N/A |
| Purchase Of Intangible Assets Classified As Investing Activities | -7,356,000.00 | N/A | -7,090,000.00 | N/A |
| Proceeds From Government Grants Classified As Investing Activities | N/A | N/A | 1,011,000.00 | N/A |
| Cash Advances And Loans Made To Other Parties Classified As Investing Activities | -2,250,000.00 | N/A | N/A | N/A |
| Cash Receipts From Repayment Of Advances And Loans Made To Other Parties Classified As Investing Activities | 8,671,000.00 | N/A | 7,430,000.00 | N/A |
| Interest Received Classified As Investing Activities | 1,719,000.00 | N/A | 10,467,000.00 | N/A |
| Other Inflows Outflows Of Cash Classified As Investing Activities | 131,000.00 | N/A | -46,000.00 | N/A |
| Cash Flows From Used In Investing Activities | -10,624,000.00 | N/A | -58,638,000.00 | N/A |
| Proceeds From Borrowings Classified As Financing Activities | 885,000,000.00 | N/A | 487,000,000.00 | N/A |
| Repayments Of Borrowings Classified As Financing Activities | -907,008,000.00 | N/A | -728,760,000.00 | N/A |
| Payments Of Lease Liabilities Classified As Financing Activities | -14,740,000.00 | N/A | -15,232,000.00 | N/A |
| Dividends Paid Classified As Financing Activities | -35,975,000.00 | N/A | -38,156,000.00 | N/A |
| Cash Flows From Used In Financing Activities | -72,723,000.00 | N/A | -268,118,000.00 | N/A |
| Increase (decrease) in cash and cash equivalents after effect of exchange rate changes | 25,047,000.00 | N/A | 6,639,000.00 | N/A |
| Cash and cash equivalents | 78,468,000.00 | 53,421,000.00 | 85,107,000.00 | 78,468,000.00 |
Please note that some sums might not add up.
HRMDKARA0000
LEI74780000O0R8ZVGJJO27
SectorPharmaceuticals, Biotechnology & Life Sciences
IndustryKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.